The Alternative & Renewable technologies (Art) fund is to complement TPG's existing biotech funds and the broader leveraged buyout portfolios.
US-based private equity firm TPG has started raising a planned-$500m clean-tech growth equity fund with corporations seen as ideal cornerstone investors.
The Alternative & Renewable technologies (Art) fund is to complement TPG’s existing biotech funds and the broader leveraged buyout portfolios.
Geoff Duyk (pictured), co-founder of TPG Biotech, will be partner and managing director (MD) of the Art fund, with Patrick McCroskey, also from the biotech unit, as the other MD.
One part of the planned fund will look at…
